Our Board of Directors represent the diverse communities within the regenerative medicine movement. Clinic practitioners, researchers, patients, and regulators all share a common goal, but with different visions. Our leadership, including this and our other boards, reflect an example of the larger system working together to bring cohesiveness to these communities, based on our "interests" for patients, rather than our "positions."

Board Members

Theresa Taylor, Acting Director
Theresa Taylor, Acting Director

Taylored Treats

Doug Oliver, M.S.W.
Doug Oliver, M.S.W.

RegenConBio, LLC

Clay Graybeal, Ph.D., M.S.W.
Clay Graybeal, Ph.D., M.S.W.

University of New England

David B. Harrell, Ph.D.
David B. Harrell, Ph.D.

Harrell BioScience Consulting, LLC

Keith March, MD, Ph.D.
Keith March, MD, Ph.D.

University of Florida

Dimitry Shvartsman, Ph.D.
Dimitry Shvartsman, Ph.D.

Senior Research Manager Harvard Stem Cell Institute

Keith Uselton, CPA/APV
Keith Uselton, CPA/APV

Principal, Uselton, Clay & Bright

Samantha Wilkinson, BS
Samantha Wilkinson, BS

Patients For Stem Cells